Description

PharmaQo Drostanolon P 100 is a pharmaceutical-grade injectable delivering 100 mg/mL Drostanolone Propionate, a compound studied in research settings for its androgenic activity, anti-catabolic properties, and potential use in estrogen-sensitive condition models.

With its short ester, Drostanolone Propionate offers rapid action, making it suitable for studies requiring precise, short-term anabolic investigation.

Product Details:
Active Ingredient:

• Drostanolone Propionate

Concentration: 100 mg/mL

Form: Injectable solution (intramuscular)

Vial Size: 10 mL multidose vial

Pharmacokinetics:
Drostanolone Propionate has an approximate half-life of 2–3 days, often requiring administration every other day or per research protocol.

Usage Recommendations:

• Indications (Research Context): Investigational use in androgen receptor studies, anti-catabolic trials, estrogen-related condition models (not approved for human use)

• Typical Dosage (Research Use): 300–500 mg per week, divided across multiple doses

• Monitoring: Androgenic markers, lipid levels, liver enzymes, cardiovascular health

• Cycle/Duration: 6–10 weeks, per research guidelines

Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always follow local research laws and ethical guidelines.

Short Description

PharmaQo Drostanolon P 100 is a 100 mg/mL Drostanolone Propionate injectable designed for investigational research on androgenic activity and anti-catabolic effects.